In an investor call on Wednesday, Chief Scientific and Product Officer Dan Skovronsky said this outcome sheds further light on how incretins may have a positive effect on other diseases independent from weight loss. Lilly is also testing tirzepatide with the interleukin blocker Omvoh in Phase 3b trials of Crohns disease and ulcerative colitis, Skovronsky added.
Antioxidant Support Theoretically, glycine supplementswhen combined with other amino acidscould have antioxidant powers
In the UK, for oral semaglutide users, absolute number and percentages of patients by dosage formulation are provided at index and 3, 6, 9, and 12 months post-index
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight Full Text View ClinicalTrials.gov
And TRANSCEND-T2D-1, part of a separate three-trial diabetes-specific program, confirmed -2.0% HbA1c reduction and 16.8% weight loss in 537 type 2 diabetes patients (topline March 2026, published in The Lancet, June 2026)
[28] [29] Orlistat (Xenical on prescription
